3rd Annual Molecular Glue Drug Development Summit

The 3rd Annual Molecular Glue Drug Development Summit focuses on advancing the development and application of molecular glues for drug discovery, particularly in targeting challenging proteins and addressing various diseases.

Topics

• Identifying Novel Molecular Glues Through Improved Screening Assays & Proteomic Tools
• Discovering Molecular Glue by High-Throughput Neomorphic Remodeling of Effector Proteins
• Turbocharging Molecular Glue Design by Starting with Protein of Interest
• Drugging Undruggable Targets & Hard to Treat Diseases with Novel Molecular Glues
• Streamlining Screening Strategies to Identify Novel & Rational-Based Molecular Glue Drug Discovery
• Supercharging Discovery & Characterization of Molecular Glues Using High-Purity FRET-Active E2-Ubiquitin Conjugates
• Harnessing & Optimizing Ligases Binders as Molecular Glues
• Improving pharmacodynamic, toxicology and PKPD properties for molecular glues
• Expanding lead optimization platforms for systematic molecular glues
• Fireside Chat: Diving into Methods Used to Discover Novel Ligases & Molecular Glues
• Discovering a Molecular Glue Active in the Parkin Ligase & PINK1 Kinase Signaling Pathway

Who should Attend

• Scientific Director
• Researcher
• Chief Executive Officer
• Senior Scientist
• Academic Researcher
• Director of Protein Chemistry
• Senior Director – Oncology Chemistry
• Vice President & Head of Biology
• Head of Technology Platform
• Chief Technology Officer